Mangrove Partners’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,031,965
| Closed | -$9.01M | – | 104 |
|
|
2020
Q3 | $9.01M | Sell |
3,031,965
-98,230
| -3% | -$292K | 1.14% | 24 |
|
|
2020
Q2 | $14.5M | Sell |
3,130,195
-1,225,221
| -28% | -$5.66M | 3.53% | 9 |
|
|
2020
Q1 | $16.8M | Buy |
4,355,416
+2,807,100
| +181% | +$10.8M | 2.31% | 14 |
|
|
2019
Q4 | $5.81M | Sell |
1,548,316
-960,522
| -38% | -$3.6M | 0.85% | 26 |
|
|
2019
Q3 | $13.3M | Sell |
2,508,838
-1,328,343
| -35% | -$7.05M | 1.61% | 21 |
|
|
2019
Q2 | $14.7M | Buy |
3,837,181
+380,140
| +11% | +$1.46M | 1.67% | 17 |
|
|
2019
Q1 | $17.6M | Buy |
3,457,041
+1,088,711
| +46% | +$5.55M | 2.36% | 15 |
|
|
2018
Q4 | $4.55M | Buy |
2,368,330
+690,386
| +41% | +$1.33M | 0.61% | 33 |
|
|
2018
Q3 | $6.34M | Hold |
1,677,944
| – | – | 0.4% | 22 |
|
|
2018
Q2 | $5.24M | Buy |
1,677,944
+169,635
| +11% | +$529K | 0.34% | 23 |
|
|
2018
Q1 | $3.61M | Buy |
1,508,309
+583,661
| +63% | +$1.4M | 0.23% | 27 |
|
|
2017
Q4 | $3.62M | Buy |
+924,648
| New | +$3.62M | 0.49% | 25 |
|